Shandong Provincial Hospital
🇨🇳China
- Country
- 🇨🇳China
- Ownership
- Private
- Established
- 2022-03-18
- Employees
- -
- Market Cap
- -
- Website
- http://www.sph.com.cn
Orelabrutinib, Rituximab and Combination Chemotherapy in Newly-diagnosed Aggressive B-cell Non-Hodgkin Lymphoma
Phase 3
Recruiting
- Conditions
- High Grade B-Cell Lymphoma With MYC and BCL2 and/or BCL6 RearrangementsMantle Cell LymphomaB-cell NonHodgkin LymphomaHigh Grade B-Cell Lymphoma, Not Otherwise SpecifiedDiffuse Large B-cell Lymphoma
- Interventions
- Drug: Orelabrutinib+R-CHOP; Orelabrutinib+R-DA-EPOCH; Orelabrutinib+R-HD MTX;Orelabrutinib+R+other chemotherapies
- First Posted Date
- 2021-10-28
- Last Posted Date
- 2021-11-19
- Lead Sponsor
- Shandong Provincial Hospital
- Target Recruit Count
- 130
- Registration Number
- NCT05097443
- Locations
- 🇨🇳
Shandong Provincial Hospital, Jinan, Shandong, China
HBOT in the Treatment and Prevention of aGVHD
Not Applicable
Recruiting
- Conditions
- Acute-graft-versus-host DiseaseHyperbaric Oxygen Therapy
- Interventions
- Device: Hyperbaric oxygen therapy
- First Posted Date
- 2021-10-14
- Last Posted Date
- 2021-10-14
- Lead Sponsor
- Shandong Provincial Hospital
- Target Recruit Count
- 100
- Registration Number
- NCT05078073
- Locations
- 🇨🇳
Shandong Provincial Hospital, Jinan, Shandong, China
Efficacy and Safety of Micafungin for Injection in Prevention and Treatment of Fungal Infection in Hematological Tumors
Phase 4
- Conditions
- Hematological Tumors Patients With High Risk Factors of Invasive Fungal Disease
- Interventions
- First Posted Date
- 2021-02-04
- Last Posted Date
- 2021-02-04
- Lead Sponsor
- Shandong Provincial Hospital
- Target Recruit Count
- 230
- Registration Number
- NCT04738955
- Locations
- 🇨🇳
Department of Hematology, Provincial Hospital Affiliated to Shandong University, Jinan, Shandong, China
Hyperbaric Oxygen Therapy for Hemorrhagic Cystitis Post HSCT
Not Applicable
Recruiting
- Conditions
- Stem Cell Transplant Complications
- Interventions
- Procedure: Hyperbaric oxygen therapy
- First Posted Date
- 2020-08-06
- Last Posted Date
- 2021-09-08
- Lead Sponsor
- Shandong Provincial Hospital
- Target Recruit Count
- 150
- Registration Number
- NCT04502628
- Locations
- 🇨🇳
Shandong Provincial Hospital, Jinan, Shandong, China
R2 and Combination Chemotherapy Versus R and Combination Chemotherapy in Newly Diagnosed Highly Aggressive B-NHL
Phase 4
- Conditions
- Lymphoma, B-Cell
- Interventions
- Drug: R2-combination chemotherapyDrug: R-combination chemotherapy
- First Posted Date
- 2019-11-05
- Last Posted Date
- 2019-11-05
- Lead Sponsor
- Shandong Provincial Hospital
- Target Recruit Count
- 200
- Registration Number
- NCT04152577
- Locations
- 🇨🇳
Department of Hematology, Provincial Hospital Affiliated to Shandong University, Jin'an, Shandong, China
Study of PD-1 Monoclonal Antibody in Combination With Chemotherapy in Patients With RR NHL
Phase 4
- Conditions
- Relapsed/Refractory Non-Hodgkin's Lymphoma
- Interventions
- Drug: PD-1 combined with chemotherapyDrug: chemotherapy
- First Posted Date
- 2019-10-22
- Last Posted Date
- 2019-10-22
- Lead Sponsor
- Shandong Provincial Hospital
- Target Recruit Count
- 120
- Registration Number
- NCT04134247
- Locations
- 🇨🇳
Department of Hematology, Shandong Provincial Hospital, Jinan, Shandong, China
The Relationship Between NK Cell and Graves' Disease
- Conditions
- Graves Disease
- First Posted Date
- 2019-10-22
- Last Posted Date
- 2021-04-14
- Lead Sponsor
- Shandong Provincial Hospital
- Target Recruit Count
- 200
- Registration Number
- NCT04135573
- Locations
- 🇨🇳
Shandong Provincial Hospital, Jinan, Shandong, China
Microwave Ablation in Combination With Camrelizumab Versus Camrelizumab in Metastatic Non-small-cell Lung Cancer
Phase 2
- Conditions
- NSCLC Stage IV
- Interventions
- Other: Camrelizumab plus microwave ablation
- First Posted Date
- 2019-09-25
- Last Posted Date
- 2020-11-02
- Lead Sponsor
- Shandong Provincial Hospital
- Target Recruit Count
- 200
- Registration Number
- NCT04102982
- Locations
- 🇨🇳
Binzhou Medical University Hospital, Binzhou, Shandong, China
🇨🇳Liaocheng Cancer Hospital, Liaocheng, Shandong, China
🇨🇳Jinan Military General Hospital, Jinan, Shandong, China
The Prevalence of Serum Thyroid Hormone Autoantibodies in Autoimmune Thyroid Diseases
- Conditions
- Autoimmune Thyroid Disease
- First Posted Date
- 2019-09-03
- Last Posted Date
- 2021-04-14
- Lead Sponsor
- Shandong Provincial Hospital
- Target Recruit Count
- 600
- Registration Number
- NCT04075851
- Locations
- 🇨🇳
Shandong Province Hospital, Jinan, Shandong, China
Pituitary Adenoma and Serum Lipid
- Conditions
- Pituitary Adenoma 1, Acth-Secreting
- First Posted Date
- 2019-07-16
- Last Posted Date
- 2022-05-11
- Lead Sponsor
- Shandong Provincial Hospital
- Target Recruit Count
- 1000
- Registration Number
- NCT04021212
- Locations
- 🇨🇳
Shandong Provincial Hospital, Jinan, Shandong, China
© Copyright 2025. All Rights Reserved by MedPath